Variant report
Variant | nsv462976 |
---|---|
Chromosome Location | chr6:65529577-65585411 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs114325549 | chr6:65532021-65532022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115530205 | chr6:65532025-65532026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs575263635 | chr6:65532026-65532027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs375470062 | chr6:65532041-65532042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544371794 | chr6:65532044-65532045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564651323 | chr6:65532078-65532079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs578076110 | chr6:65532093-65532094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529272164 | chr6:65532133-65532134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183637453 | chr6:65532143-65532144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188297913 | chr6:65532184-65532185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191604255 | chr6:65532249-65532250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142222949 | chr6:65532296-65532297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs184707019 | chr6:65532339-65532340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561654773 | chr6:65532365-65532366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530566951 | chr6:65532370-65532371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142137739 | chr6:65532372-65532373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189975899 | chr6:65532394-65532395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181627351 | chr6:65532397-65532398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546787517 | chr6:65532426-65532427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566400670 | chr6:65532476-65532477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535341699 | chr6:65532478-65532479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs147764984 | chr6:65532499-65532500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536792101 | chr6:65532509-65532510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs376779088 | chr6:65532512-65532513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs201012275 | chr6:65532528-65532529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs368790430 | chr6:65532582-65532583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs538242132 | chr6:65532648-65532649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557931285 | chr6:65532680-65532681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs578061514 | chr6:65532715-65532716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs540446273 | chr6:65532737-65532738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369126253 | chr6:65532742-65532743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560648459 | chr6:65532760-65532761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561958565 | chr6:65532764-65532765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574321344 | chr6:65532793-65532794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543332747 | chr6:65532809-65532810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs76702528 | chr6:65532816-65532817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534677256 | chr6:65532817-65532818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530376915 | chr6:65532859-65532860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs141160182 | chr6:65532887-65532888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563991123 | chr6:65532915-65532916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs28639803 | chr6:65532919-65532920 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs546316592 | chr6:65532938-65532939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566313397 | chr6:65532946-65532947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34714059 | chr6:65533004-65533005 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs548819279 | chr6:65533025-65533026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10498828 | chr6:65533066-65533067 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs118150295 | chr6:65533067-65533068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs17486740 | chr6:65533078-65533079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571583411 | chr6:65533098-65533099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs147950139 | chr6:65533133-65533134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65532000-65532800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr6:65532800-65533400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
3 | chr6:65533400-65534000 | Active TSS | Pancreatic Islets | Pancreatic Islet |
4 | chr6:65533600-65534000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr6:65534000-65534200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
6 | chr6:65543800-65544600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr6:65570000-65571200 | Enhancers | Adipose Nuclei | Adipose |
8 | chr6:65571200-65572200 | Weak transcription | Adipose Nuclei | Adipose |
9 | chr6:65572200-65572400 | Enhancers | Adipose Nuclei | Adipose |